4th Quarter - Report
SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.4356 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022; Matters related to Gene Therapy funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY FRISK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.